{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T14:52:14Z","timestamp":1763563934963,"version":"3.37.3"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2016,12,12]],"date-time":"2016-12-12T00:00:00Z","timestamp":1481500800000},"content-version":"vor","delay-in-days":11,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["26893275"],"award-info":[{"award-number":["26893275"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003427","name":"Gout Research Foundation of Japan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003427","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Fluids Barriers CNS"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12987-016-0046-x","type":"journal-article","created":{"date-parts":[[2016,12,12]],"date-time":"2016-12-12T13:10:13Z","timestamp":1481548213000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Immunohistochemical and in situ hybridization study of urate transporters GLUT9\/URATv1, ABCG2, and URAT1 in the murine brain"],"prefix":"10.1186","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0524-3410","authenticated-orcid":false,"given":"Naoko H.","family":"Tomioka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshifuru","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tappei","family":"Takada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeru","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunya","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Hosoyamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,12,12]]},"reference":[{"key":"46_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/jpet.107.129031","volume":"324","author":"MK Kutzing","year":"2008","unstructured":"Kutzing MK, Firestein BL. Altered uric acid levels and disease states. J Pharmacol Exp Ther. 2008;324:1\u20137.","journal-title":"J Pharmacol Exp Ther"},{"key":"46_CR2","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s11910-012-0282-7","volume":"12","author":"X Chen","year":"2012","unstructured":"Chen X, Wu G, Schwarzschild MA. Urate in Parkinson\u2019s disease: more than a biomarker? Curr Neurol Neurosci Rep. 2012;12:367\u201375.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"46_CR3","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1002\/acn3.167","volume":"2","author":"H Matsuo","year":"2015","unstructured":"Matsuo H, Tomiyama H, Satake W, Chiba T, Onoue H, Kawamura Y, Nakayama A, Shimizu S, Sakiyama M, Funayama M, Nishioka K, Shimizu T, Kaida K, Kamakura K, Toda T, Hattori N, Shinomiya N. ABCG2 variant has opposing effects on onset ages of Parkinson\u2019s disease and gout. Ann Clin Transl Neurol. 2015;2:302\u20136.","journal-title":"Ann Clin Transl Neurol"},{"key":"46_CR4","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1002\/ana.24281","volume":"76","author":"KC Simon","year":"2014","unstructured":"Simon KC, Eberly S, Gao X, Oakes D, Tanner CM, Shoulson I, Fahn S, Schwarzschild MA, Ascherio A, Parkinson Study G. Mendelian randomization of serum urate and parkinson disease progression. Ann Neurol. 2014;76:862\u20138.","journal-title":"Ann Neurol"},{"key":"46_CR5","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1007\/s12031-010-9409-y","volume":"43","author":"MF Facheris","year":"2011","unstructured":"Facheris MF, Hicks AA, Minelli C, Hagenah JM, Kostic V, Campbell S, Hayward C, Volpato CB, Pattaro C, Vitart V, Wright A, Campbell H, Klein C, Pramstaller PP. Variation in the uric acid transporter gene SLC2A9 and its association with AAO of Parkinson\u2019s disease. J Mol Neurosci. 2011;43:246\u201350.","journal-title":"J Mol Neurosci"},{"key":"46_CR6","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1002\/mds.25507","volume":"28","author":"I Gonzalez-Aramburu","year":"2013","unstructured":"Gonzalez-Aramburu I, Sanchez-Juan P, Jesus S, Gorostidi A, Fernandez-Juan E, Carrillo F, Sierra M, Gomez-Garre P, Caceres-Redondo MT, Berciano J, Ruiz-Martinez J, Combarros O, Mir P, Infante J. Genetic variability related to serum uric acid concentration and risk of Parkinson\u2019s disease. Mov Disord. 2013;28:1737\u201340.","journal-title":"Mov Disord"},{"key":"46_CR7","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1073\/pnas.1217296110","volume":"110","author":"X Chen","year":"2013","unstructured":"Chen X, Burdett TC, Desjardins CA, Logan R, Cipriani S, Xu Y, Schwarzschild MA. Disrupted and transgenic urate oxidase alter urate and dopaminergic neurodegeneration. Proc Natl Acad Sci USA. 2013;110:300\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"46_CR8","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1111\/jnc.12038","volume":"123","author":"L Gong","year":"2012","unstructured":"Gong L, Zhang QL, Zhang N, Hua WY, Huang YX, Di PW, Huang T, Xu XS, Liu CF, Hu LF, Luo WF. Neuroprotection by urate on 6-OHDA-lesioned rat model of Parkinson\u2019s disease: linking to Akt\/GSK3beta signaling pathway. J Neurochem. 2012;123:876\u201385.","journal-title":"J Neurochem"},{"key":"46_CR9","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1001\/jamaneurol.2013.5528","volume":"71","author":"MA Schwarzschild","year":"2014","unstructured":"Parkinson Study Group S-PDI, Schwarzschild MA, Ascherio A, Beal MF, Cudkowicz ME, Curhan GC, Hare JM, Hooper DC, Kieburtz KD, Macklin EA, Oakes D, Rudolph A, Shoulson I, Tennis MK, Espay AJ, Gartner M, Hung A, Bwala G, Lenehan R, Encarnacion E, Ainslie M, Castillo R, Togasaki D, Barles G, Friedman JH, Niles L, Carter JH, Murray M, Goetz CG, Jaglin J, et al. Inosine to increase serum and cerebrospinal fluid urate in Parkinson disease: a randomized clinical trial. JAMA Neurol. 2014;71:141\u201350.","journal-title":"JAMA Neurol"},{"key":"46_CR10","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/mds.26483","volume":"31","author":"S Bhattacharyya","year":"2016","unstructured":"Bhattacharyya S, Bakshi R, Logan R, Ascherio A, Macklin EA, Schwarzschild MA. Oral inosine persistently elevates plasma antioxidant capacity in Parkinson\u2019s disease. Mov Disord. 2016;31:417\u201321.","journal-title":"Mov Disord"},{"key":"46_CR11","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1001\/archneurol.2009.247","volume":"66","author":"A Ascherio","year":"2009","unstructured":"Ascherio A, LeWitt PA, Xu K, Eberly S, Watts A, Matson WR, Marras C, Kieburtz K, Rudolph A, Bogdanov MB, Schwid SR, Tennis M, Tanner CM, Beal MF, Lang AE, Oakes D, Fahn S, Shoulson I, Schwarzschild MA, Parkinson Study Group DI. Urate as a predictor of the rate of clinical decline in Parkinson disease. Arch Neurol. 2009;66:1460\u20138.","journal-title":"Arch Neurol"},{"key":"46_CR12","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nature742","volume":"417","author":"A Enomoto","year":"2002","unstructured":"Enomoto A, Kimura H, Chairoungdua A, Shigeta Y, Jutabha P, Cha SH, Hosoyamada M, Takeda M, Sekine T, Igarashi T, Matsuo H, Kikuchi Y, Oda T, Ichida K, Hosoya T, Shimokata K, Niwa T, Kanai Y, Endou H. Molecular identification of a renal urate anion exchanger that regulates blood urate levels. Nature. 2002;417:447\u201352.","journal-title":"Nature"},{"key":"46_CR13","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/2045-8118-10-31","volume":"10","author":"NH Tomioka","year":"2013","unstructured":"Tomioka NH, Nakamura M, Doshi M, Deguchi Y, Ichida K, Morisaki T, Hosoyamada M. Ependymal cells of the mouse brain express urate transporter 1 (URAT1). Fluids Barriers CNS. 2013;10:31.","journal-title":"Fluids Barriers CNS"},{"key":"46_CR14","doi-asserted-by":"publisher","first-page":"e28426","DOI":"10.4161\/tisb.28426","volume":"2","author":"AJ Jimenez","year":"2014","unstructured":"Jimenez AJ, Dominguez-Pinos MD, Guerra MM, Fernandez-Llebrez P, Perez-Figares JM. Structure and function of the ependymal barrier and diseases associated with ependyma disruption. Tissue Barriers. 2014;2:e28426.","journal-title":"Tissue Barriers"},{"key":"46_CR15","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1177\/0192623310394214","volume":"39","author":"C Johanson","year":"2011","unstructured":"Johanson C, Stopa E, McMillan P, Roth D, Funk J, Krinke G. The distributional nexus of choroid plexus to cerebrospinal fluid, ependyma and brain: toxicologic\/pathologic phenomena, periventricular destabilization, and lesion spread. Toxicol Pathol. 2011;39:186\u2013212.","journal-title":"Toxicol Pathol"},{"key":"46_CR16","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1002\/cne.22273","volume":"518","author":"A Mullier","year":"2010","unstructured":"Mullier A, Bouret SG, Prevot V, Dehouck B. Differential distribution of tight junction proteins suggests a role for tanycytes in blood-hypothalamus barrier regulation in the adult mouse brain. J Comp Neurol. 2010;518:943\u201362.","journal-title":"J Comp Neurol"},{"key":"46_CR17","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/0169-328X(94)90254-2","volume":"21","author":"T Petrov","year":"1994","unstructured":"Petrov T, Howarth AG, Krukoff TL, Stevenson BR. Distribution of the tight junction-associated protein ZO-1 in circumventricular organs of the CNS. Brain Res Mol Brain Res. 1994;21:235\u201346.","journal-title":"Brain Res Mol Brain Res"},{"key":"46_CR18","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12987-015-0006-x","volume":"12","author":"S Akanuma","year":"2015","unstructured":"Akanuma S, Sakurai T, Tachikawa M, Kubo Y, Hosoya K. Transporter-mediated l-glutamate elimination from cerebrospinal fluid: possible involvement of excitatory amino acid transporters expressed in ependymal cells and choroid plexus epithelial cells. Fluids Barriers CNS. 2015;12:11.","journal-title":"Fluids Barriers CNS"},{"key":"46_CR19","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1152\/physrev.00019.2012","volume":"93","author":"D Gunzel","year":"2013","unstructured":"Gunzel D, Yu AS. Claudins and the modulation of tight junction permeability. Physiol Rev. 2013;93:525\u201369.","journal-title":"Physiol Rev"},{"key":"46_CR20","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1146\/annurev-physiol-021113-170343","volume":"77","author":"AK Mandal","year":"2015","unstructured":"Mandal AK, Mount DB. The molecular physiology of uric acid homeostasis. Annu Rev Physiol. 2015;77:323\u201345.","journal-title":"Annu Rev Physiol"},{"key":"46_CR21","doi-asserted-by":"publisher","first-page":"16229","DOI":"10.1074\/jbc.M312226200","volume":"279","author":"R Augustin","year":"2004","unstructured":"Augustin R, Carayannopoulos MO, Dowd LO, Phay JE, Moley JF, Moley KH. Identification and characterization of human glucose transporter-like protein-9 (GLUT9): alternative splicing alters trafficking. J Biol Chem. 2004;279:16229\u201336.","journal-title":"J Biol Chem"},{"key":"46_CR22","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1210\/me.2005-0010","volume":"20","author":"C Keembiyehetty","year":"2006","unstructured":"Keembiyehetty C, Augustin R, Carayannopoulos MO, Steer S, Manolescu A, Cheeseman CI, Moley KH. Mouse glucose transporter 9 splice variants are expressed in adult liver and kidney and are up-regulated in diabetes. Mol Endocrinol. 2006;20:686\u201397.","journal-title":"Mol Endocrinol"},{"key":"46_CR23","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/j.1471-4159.2012.07820.x","volume":"123","author":"S Cipriani","year":"2012","unstructured":"Cipriani S, Desjardins CA, Burdett TC, Xu Y, Xu K, Schwarzschild MA. Protection of dopaminergic cells by urate requires its accumulation in astrocytes. J Neurochem. 2012;123:172\u201381.","journal-title":"J Neurochem"},{"key":"46_CR24","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1097\/00001756-200211150-00014","volume":"13","author":"HC Cooray","year":"2002","unstructured":"Cooray HC, Blackmore CG, Maskell L, Barrand MA. Localisation of breast cancer resistance protein in microvessel endothelium of human brain. Neuroreport. 2002;13:2059\u201363.","journal-title":"Neuroreport"},{"key":"46_CR25","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/j.1471-4159.2005.03369.x","volume":"95","author":"M Tachikawa","year":"2005","unstructured":"Tachikawa M, Watanabe M, Hori S, Fukaya M, Ohtsuki S, Asashima T, Terasaki T. Distinct spatio-temporal expression of ABCA and ABCG transporters in the developing and adult mouse brain. J Neurochem. 2005;95:294\u2013304.","journal-title":"J Neurochem"},{"key":"46_CR26","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1177\/33.5.3921605","volume":"33","author":"D Mitchell","year":"1985","unstructured":"Mitchell D, Ibrahim S, Gusterson BA. Improved immunohistochemical localization of tissue antigens using modified methacarn fixation. J Histochem Cytochem. 1985;33:491\u20135.","journal-title":"J Histochem Cytochem"},{"key":"46_CR27","doi-asserted-by":"publisher","first-page":"e84996","DOI":"10.1371\/journal.pone.0084996","volume":"9","author":"T Kimura","year":"2014","unstructured":"Kimura T, Takahashi M, Yan K, Sakurai H. Expression of SLC2A9 isoforms in the kidney and their localization in polarized epithelial cells. Plos ONE. 2014;9:e84996.","journal-title":"Plos ONE"},{"key":"46_CR28","doi-asserted-by":"publisher","first-page":"15501","DOI":"10.1073\/pnas.0904411106","volume":"106","author":"F Preitner","year":"2009","unstructured":"Preitner F, Bonny O, Laverriere A, Rotman S, Firsov D, Da Costa A, Metref S, Thorens B. Glut9 is a major regulator of urate homeostasis and its genetic inactivation induces hyperuricosuria and urate nephropathy. Proc Natl Acad Sci USA. 2009;106:15501\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"46_CR29","doi-asserted-by":"publisher","first-page":"4642","DOI":"10.1038\/ncomms5642","volume":"5","author":"BJ DeBosch","year":"2014","unstructured":"DeBosch BJ, Kluth O, Fujiwara H, Schurmann A, Moley K. Early-onset metabolic syndrome in mice lacking the intestinal uric acid transporter SLC2A9. Nat Commun. 2014;5:4642.","journal-title":"Nat Commun"},{"key":"46_CR30","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/nrm3351","volume":"13","author":"D Leto","year":"2012","unstructured":"Leto D, Saltiel AR. Regulation of glucose transport by insulin: traffic control of GLUT4. Nat Rev Mol Cell Biol. 2012;13:383\u201396.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"46_CR31","doi-asserted-by":"publisher","first-page":"15430","DOI":"10.1074\/jbc.M110.110593","volume":"285","author":"AJ Cura","year":"2010","unstructured":"Cura AJ, Carruthers A. Acute modulation of sugar transport in brain capillary endothelial cell cultures during activation of the metabolic stress pathway. J Biol Chem. 2010;285:15430\u20139.","journal-title":"J Biol Chem"},{"key":"46_CR32","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1253\/circj.CJ-14-1267","volume":"79","author":"S Sugihara","year":"2015","unstructured":"Sugihara S, Hisatome I, Kuwabara M, Niwa K, Maharani N, Kato M, Ogino K, Hamada T, Ninomiya H, Higashi Y, Ichida K, Yamamoto K. Depletion of uric acid due to SLC22A12 (URAT1) loss-of-function mutation causes endothelial dysfunction in hypouricemia. Circ J. 2015;79:1125\u201332.","journal-title":"Circ J"},{"key":"46_CR33","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1097\/01.ASN.0000135049.20420.E5","volume":"15","author":"T Imaoka","year":"2004","unstructured":"Imaoka T, Kusuhara H, Adachi-Akahane S, Hasegawa M, Morita N, Endou H, Sugiyama Y. The renal-specific transporter mediates facilitative transport of organic anions at the brush border membrane of mouse renal tubules. J Am Soc Nephrol. 2004;15:2012\u201322.","journal-title":"J Am Soc Nephrol"},{"key":"46_CR34","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.3233\/JAD-2010-1330","volume":"19","author":"GL Bowman","year":"2010","unstructured":"Bowman GL, Shannon J, Frei B, Kaye JA, Quinn JF. Uric acid as a CNS antioxidant. J Alzheimers Dis. 2010;19:1331\u20136.","journal-title":"J Alzheimers Dis"},{"key":"46_CR35","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00401-009-0627-8","volume":"119","author":"H Wolburg","year":"2010","unstructured":"Wolburg H, Paulus W. Choroid plexus: biology and pathology. Acta Neuropathol. 2010;119:75\u201388.","journal-title":"Acta Neuropathol"},{"key":"46_CR36","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/2045-8118-11-10","volume":"11","author":"T Brinker","year":"2014","unstructured":"Brinker T, Stopa E, Morrison J, Klinge P. A new look at cerebrospinal fluid circulation. Fluids Barriers CNS. 2014;11:10.","journal-title":"Fluids Barriers CNS"},{"key":"46_CR37","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/BF01450880","volume":"105","author":"Y Moriwaki","year":"1996","unstructured":"Moriwaki Y, Yamamoto T, Yamaguchi K, Takahashi S, Higashino K. Immunohistochemical localization of aldehyde and xanthine oxidase in rat tissues using polyclonal antibodies. Histochem Cell Biol. 1996;105:71\u20139.","journal-title":"Histochem Cell Biol"},{"key":"46_CR38","doi-asserted-by":"publisher","first-page":"7612","DOI":"10.1128\/MCB.24.17.7612-7621.2004","volume":"24","author":"M Leggas","year":"2004","unstructured":"Leggas M, Adachi M, Scheffer GL, Sun D, Wielinga P, Du G, Mercer KE, Zhuang Y, Panetta JC, Johnston B, Scheper RJ, Stewart CF, Schuetz JD. Mrp4 confers resistance to topotecan and protects the brain from chemotherapy. Mol Cell Biol. 2004;24:7612\u201321.","journal-title":"Mol Cell Biol"},{"key":"46_CR39","doi-asserted-by":"publisher","first-page":"F763","DOI":"10.1152\/ajprenal.00405.2002","volume":"284","author":"DH Sweet","year":"2003","unstructured":"Sweet DH, Chan LM, Walden R, Yang XP, Miller DS, Pritchard JB. Organic anion transporter 3 (Slc22a8) is a dicarboxylate exchanger indirectly coupled to the Na+\u00a0gradient. Am J Physiol Renal Physiol. 2003;284:F763\u20139.","journal-title":"Am J Physiol Renal Physiol"},{"key":"46_CR40","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1159\/000074539","volume":"13","author":"A Bakhiya","year":"2003","unstructured":"Bakhiya A, Bahn A, Burckhardt G, Wolff N. Human organic anion transporter 3 (hOAT3) can operate as an exchanger and mediate secretory urate flux. Cell Physiol Biochem. 2003;13:249\u201356.","journal-title":"Cell Physiol Biochem"},{"key":"46_CR41","doi-asserted-by":"publisher","first-page":"26834","DOI":"10.1074\/jbc.C800156200","volume":"283","author":"N Anzai","year":"2008","unstructured":"Anzai N, Ichida K, Jutabha P, Kimura T, Babu E, Jin CJ, Srivastava S, Kitamura K, Hisatome I, Endou H, Sakurai H. Plasma urate level is directly regulated by a voltage-driven urate efflux transporter URATv1 (SLC2A9) in humans. J Biol Chem. 2008;283:26834\u20138.","journal-title":"J Biol Chem"},{"key":"46_CR42","doi-asserted-by":"publisher","first-page":"10338","DOI":"10.1073\/pnas.0901249106","volume":"106","author":"OM Woodward","year":"2009","unstructured":"Woodward OM, Kottgen A, Coresh J, Boerwinkle E, Guggino WB, Kottgen M. Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout. Proc Natl Acad Sci USA. 2009;106:10338\u201342.","journal-title":"Proc Natl Acad Sci USA"},{"key":"46_CR43","doi-asserted-by":"publisher","first-page":"5ra11","DOI":"10.1126\/scitranslmed.3000237","volume":"1","author":"H Matsuo","year":"2009","unstructured":"Matsuo H, Takada T, Ichida K, Nakamura T, Nakayama A, Ikebuchi Y, Ito K, Kusanagi Y, Chiba T, Tadokoro S, Takada Y, Oikawa Y, Inoue H, Suzuki K, Okada R, Nishiyama J, Domoto H, Watanabe S, Fujita M, Morimoto Y, Naito M, Nishio K, Hishida A, Wakai K, Asai Y, Niwa K, Kamakura K, Nonoyama S, Sakurai Y, Hosoya T, et al. Common defects of ABCG2, a high-capacity urate exporter, cause gout: a function-based genetic analysis in a Japanese population. Sci Transl Med. 2009;1:5ra11.","journal-title":"Sci Transl Med"},{"key":"46_CR44","doi-asserted-by":"publisher","first-page":"E831","DOI":"10.1152\/ajpendo.00296.2009","volume":"297","author":"M Doblado","year":"2009","unstructured":"Doblado M, Moley KH. Facilitative glucose transporter 9, a unique hexose and urate transporter. Am J Physiol Endocrinol Metab. 2009;297:E831\u20135.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"46_CR45","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1111\/j.1471-4159.2009.06151.x","volume":"110","author":"MA Castro","year":"2009","unstructured":"Castro MA, Beltran FA, Brauchi S, Concha II. A metabolic switch in brain: glucose and lactate metabolism modulation by ascorbic acid. J Neurochem. 2009;110:423\u201340.","journal-title":"J Neurochem"},{"key":"46_CR46","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s00431-002-0939-3","volume":"161","author":"J Klepper","year":"2002","unstructured":"Klepper J, Voit T. Facilitated glucose transporter protein type 1 (GLUT1) deficiency syndrome: impaired glucose transport into brain\u2014a review. Eur J Pediatr. 2002;161:295\u2013304.","journal-title":"Eur J Pediatr"},{"key":"46_CR47","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1056\/NEJM199109053251006","volume":"325","author":"DC De Vivo","year":"1991","unstructured":"De Vivo DC, Trifiletti RR, Jacobson RI, Ronen GM, Behmand RA, Harik SI. Defective glucose transport across the blood-brain barrier as a cause of persistent hypoglycorrhachia, seizures, and developmental delay. N Engl J Med. 1991;325:703\u20139.","journal-title":"N Engl J Med"}],"container-title":["Fluids and Barriers of the CNS"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-016-0046-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12987-016-0046-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-016-0046-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T09:46:43Z","timestamp":1589536003000},"score":1,"resource":{"primary":{"URL":"https:\/\/fluidsbarrierscns.biomedcentral.com\/articles\/10.1186\/s12987-016-0046-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["46"],"URL":"https:\/\/doi.org\/10.1186\/s12987-016-0046-x","relation":{},"ISSN":["2045-8118"],"issn-type":[{"type":"electronic","value":"2045-8118"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"12 October 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"22"}}